Cambridge Advisors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,200	Closed	-$222K	–	176
2024 Q4	$222K	Hold	1,200	–	–	0.05%	163
2024 Q3	$236K	Hold	1,200	–	–	0.05%	159
2024 Q2	$248K	Hold	1,200	–	–	0.06%	157
2024 Q1	$325K	Hold	1,200	–	–	0.08%	138
2023 Q4	$284K	Hold	1,200	–	–	0.07%	142
2023 Q3	$235K	Hold	1,200	–	–	0.06%	151
2023 Q2	$252K	Hold	1,200	–	–	0.06%	147
2023 Q1	$242K	Hold	1,200	–	–	0.06%	165
2022 Q4	$261K	Hold	1,200	–	–	0.07%	154
2022 Q3	$236K	Hold	1,200	–	–	0.07%	154
2022 Q2	$257K	Hold	1,200	–	–	0.07%	157
2022 Q1	$341K	Hold	1,200	–	–	0.08%	141
2021 Q4	$452K	Sell	1,200 -100	-8%	-$37.7K	0.1%	130
2021 Q3	$536K	Sell	1,300 -200	-13%	-$82.5K	0.13%	113
2021 Q2	$555K	Hold	1,500	–	–	0.13%	107
2021 Q1	$435K	Hold	1,500	–	–	0.11%	116
2020 Q4	$375K	Sell	1,500 -300	-17%	-$75K	0.1%	119
2020 Q3	$408K	Hold	1,800	–	–	0.12%	101
2020 Q2	$314K	Hold	1,800	–	–	0.1%	115
2020 Q1	$227K	Sell	1,800 -200	-10%	-$25.2K	0.08%	126
2019 Q4	$306K	Hold	2,000	–	–	0.09%	121
2019 Q3	$265K	Hold	2,000	–	–	0.09%	113
2019 Q2	$284K	Hold	2,000	–	–	0.09%	113
2019 Q1	$291K	Hold	2,000	–	–	0.1%	114
2018 Q4	$226K	Hold	2,000	–	–	0.08%	122
2018 Q3	$269K	Hold	2,000	–	–	0.09%	121
2018 Q2	$225K	Hold	2,000	–	–	0.08%	129
2018 Q1	$213K	Hold	2,000	–	–	0.08%	133
2017 Q4	$219K	Hold	2,000	–	–	0.08%	128
2017 Q3	$216K	Hold	2,000	–	–	0.08%	127
2017 Q2	$202K	Buy	+2,000	New	+$202K	0.08%	128